Oncologists appeal dismissal of Medicare drug reimbursement cut lawsuit
A group of oncologists on Monday urged a federal appeals court to revive a lawsuit challenging a “harmful and indiscriminate” 2% cut to Medicare reimbursements for medications including cancer drugs that are administered by healthcare providers.
